Business
Expansion Global Distribution Agreement with GE
Imaging Biometrics Limited has expanded its global distribution agreement with GE HealthCare to include FTB Express maps and QSMetric, enhancing access to advanced neuroimaging solutions. This amendment builds upon the existing distribution of IB Neuro and Delta T1 maps, which are crucial for brain tumor diagnosis and treatment monitoring. FTB Express offers accelerated processing for Fractional Tumor Burden maps, providing rapid insights into tumor versus non-tumor tissue and treatment effects. QSMetric, a patented quantitative susceptibility mapping software, supports a wider range of clinical applications including neurodegenerative disease assessment and neurosurgery targeting. Disclaimer*
About this update from Imaging Biometrics Limited
[{"type":"text","content":"\n\nDecember 10, 2025\nImaging Biometrics, Ltd\n(\"IBAI\" or the \"Company\")\n \nImaging Biometrics Expands Global Distribution Agreement with GE HealthCare to Include FTB Express Maps and QSMetric™\n \nImaging Biometrics (IB), a leader in advanced neuroimaging solutions, announces an amendment to its distribution agreement with GE HealthCare, expanding access to two innovative offerings: FTB Express maps and QSMetric.\n \nThe agreement already includes IB Neuro and Delta T1 maps, widely adopted together to assist clinicians in diagnosing, planning, and monitoring treatment response for brain tumor patients. Delta T1 maps provide rapid, objective delineation of contrast-enhancing regions, while IB Neuro generates standardized (quantitative) MR DSC perfusion images of relative cerebral blood volume (sRCBV), which eliminates manual tissue normalization. These outputs serve as inputs for Fractional Tumor Burden (FTB) maps, which deliver automated visualization of tumor versus non-tumor tissue and treatment effects within enhancing regions. FTB Express accelerates this process, enabling clinicians to quickly access actionable insights for patient care.\n \nQSMetric is a patented quantitative susceptibility mapping software that processes gradient echo brain images to visualize tissue structures and measure susceptibility values. This capability supports a broad range of clinical applications, including targeting for deep brain stimulation (DBS) surgery, neurodegenerative disease assessment, multiple sclerosis, and more.\n \nKatie Anderson, Global MR Visualization Product Manager at GE HealthCare, said, \"We are excited to expand our collaboration with Imaging Biometrics to enable access for our customers to these clinically important capabilities.\"\n \n--ENDS-\n \nThe Directors of the Company accept responsibility for the contents of this announcement.\nFor further information, please contact:\n \n\n\n\n\nImaging Biometrics Ltd\nTrevor Brown/Dr Al Musella/Brett Skelly/Michael Schmainda\nTel: 020 7469 0930\n\n\n\n\nAlbR Capital Limited (Broker)\nLucy Williams/Heena Karani\nTel: 020 7220 9797\n\n\n\n\n \n \n \nAbout Imaging Biometrics® LLC\nIB is a wholly owned subsidiary of Imaging Biometrics, Ltd, (LON: IBAI), and focuses on delivering quantitative imaging platforms and therap...